# Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

> **NCT00841256** · PHASE3 · COMPLETED · sponsor: **Allergopharma GmbH & Co. KG** · enrollment: 207 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Grass pollen allergens in a water/glycerol solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00841256
- **Lead sponsor:** Allergopharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2012-06
- **Final completion:** 2015-08
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2015-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841256, "Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00841256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*